Comparative efficacy and safety of mesalazine-based regimens with traditional Chinese medicines in mild-to-moderate ulcerative colitis
Combining mesalazine with selected TCM formulations can enhance clinical response, reduce inflammatory cytokines, and beneficially modulate gut microbiota without increasing adverse events. CurQD or Kangfuxin may be prioritized for symptomatic improvement, Glycyrrhizae or Baitouweng for Mayo score reduction, Scutellaria for cytokine control, and Shaoyao or Glycyrrhizae for microbiota modulation. High-quality multicenter RCTs are warranted to confirm these comparative rankings.
Authors
- Dan Shi (ORCID: https://orcid.org/0000-0001-5658-4314)
- L. Chen
- Huimin Lin (ORCID: https://orcid.org/0000-0002-1679-1279)
- Yaping Su (ORCID: https://orcid.org/0000-0002-8865-1806)
- Honglin An
- Jiumao LIN
- Bin Huang
- Ruofei Li
- Huaping Wu
Institutions
- Fujian University of Traditional Chinese Medicine (CN)
- Fujian Provincial People's Hospital (CN)
- Fuzhou Maternity and Child Health Care Hospital (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2026-01-13
- DOI
- https://doi.org/10.3389/fphar.2025.1691460
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China